These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 20846128

  • 1. Successful percutaneous septal alcohol ablation after surgical myectomy.
    Kulić M, Spuzić M, Tahirović E, Sehović S, Mujacić V, Zorman D, Velebit V.
    Bosn J Basic Med Sci; 2010 Aug; 10(3):218-22. PubMed ID: 20846128
    [Abstract] [Full Text] [Related]

  • 2. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
    Kurita T, Tsuchikane E, Tanaka N, Suzuki T.
    Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
    [Abstract] [Full Text] [Related]

  • 3. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z, Wang F, Dou X, Zhang S, Pu J.
    Int J Cardiol; 2006 Sep 10; 112(1):80-4. PubMed ID: 16507323
    [Abstract] [Full Text] [Related]

  • 4. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
    Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD.
    J Am Coll Cardiol; 2001 Dec 10; 38(7):1994-2000. PubMed ID: 11738306
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous transluminal septal myocardial ablation: past, present, and future.
    Maekawa Y, Takamisawa I, Takano H, Takayama M.
    J Cardiol; 2022 Sep 10; 80(3):211-217. PubMed ID: 34924238
    [Abstract] [Full Text] [Related]

  • 6. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L, Seggewiss H, Fassbender D, Bogunovic N, Strick S, Schmidt HK, Gleichmann U.
    Z Kardiol; 1998 Mar 10; 87(3):191-201. PubMed ID: 9586154
    [Abstract] [Full Text] [Related]

  • 7. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Akita K, Maekawa Y, Kohno T, Tsuruta H, Murata M, Fukuda K.
    Heart Vessels; 2017 Nov 10; 32(11):1320-1326. PubMed ID: 28555387
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.
    Guo HC, Li JH, Jiang TY, Ren CW, Dai J, Zhou YJ, Lai YQ.
    Chin Med J (Engl); 2018 Mar 05; 131(5):527-531. PubMed ID: 29483385
    [Abstract] [Full Text] [Related]

  • 9. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717
    [Abstract] [Full Text] [Related]

  • 10. Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation.
    Nishimura RA, Seggewiss H, Schaff HV.
    Circ Res; 2017 Sep 15; 121(7):771-783. PubMed ID: 28912182
    [Abstract] [Full Text] [Related]

  • 11. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
    Zheng SW, Shi HY, Dai JJ, Chen H, Wu WH, Qiu XB.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr 24; 48(4):294-301. PubMed ID: 32370480
    [Abstract] [Full Text] [Related]

  • 12. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M, Dokainish H, Lakkis N.
    J Interv Cardiol; 2006 Aug 24; 19(4):319-27. PubMed ID: 16881978
    [Abstract] [Full Text] [Related]

  • 13. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
    Zhu C, Tang B, Cui H, Wang S, Xiao M, Chen Z, Meng Y, Zhao S, Song Y, Yu Q, Wang S.
    J Card Surg; 2019 Jul 24; 34(7):533-540. PubMed ID: 31111576
    [Abstract] [Full Text] [Related]

  • 14. Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathy.
    Arslan F, Akdim F, Ten Berg JM.
    Catheter Cardiovasc Interv; 2021 Feb 15; 97(3):488-492. PubMed ID: 32808736
    [Abstract] [Full Text] [Related]

  • 15. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
    Moravsky G, Bruchal-Garbicz B, Jamorski M, Ralph-Edwards A, Gruner C, Williams L, Woo A, Yang H, Laczay B, Rakowski H, Carasso S.
    J Am Soc Echocardiogr; 2013 Aug 15; 26(8):893-900. PubMed ID: 23800507
    [Abstract] [Full Text] [Related]

  • 16. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.
    Fitzgerald P, Kusumoto F.
    J Interv Card Electrophysiol; 2018 Aug 15; 52(3):403-408. PubMed ID: 30097789
    [Abstract] [Full Text] [Related]

  • 17. A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy.
    da Silva Menezes Junior A, de Oliveira ALV, Maia TA, Botelho SM.
    Curr Cardiol Rev; 2023 Aug 15; 19(4):e240323214927. PubMed ID: 36999417
    [Abstract] [Full Text] [Related]

  • 18. Contrast-enhanced computed tomography with myocardial three-dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy.
    Hamatani Y, Amaki M, Kanzaki H, Yamashita K, Nakashima Y, Shibata A, Okada A, Takahama H, Hasegawa T, Shimahara Y, Sugano Y, Fujita T, Shiraishi I, Yasuda S, Kobayashi J, Anzai T.
    ESC Heart Fail; 2017 Nov 15; 4(4):665-669. PubMed ID: 29154429
    [Abstract] [Full Text] [Related]

  • 19. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.
    Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, Dolney DO, Blackstone EH.
    Ann Thorac Surg; 2008 Jan 15; 85(1):127-33. PubMed ID: 18154797
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy through non-left anterior descending septal perforators.
    Imori Y, Takano H, Kitamura M, Aoyama R, Sangen H, Kenta O, Matsuda J, Kubota Y, Tokita Y, Yamamoto T, Asai K, Takayama M, Shimizu W.
    Heart Vessels; 2020 May 15; 35(5):647-654. PubMed ID: 31641886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.